Actively Recruiting
Effect of Comprehensive Swallowing Rehabilitation in Patients With Multiple System Atrophy: A Randomized Controlled Trial
Led by Seoul National University Hospital · Updated on 2026-04-27
24
Participants Needed
1
Research Sites
8 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Multiple system atrophy (MSA) is a fast-progressing disease affecting movement and autonomic functions, often leading to swallowing difficulties known as dysphagia. This research evaluates the effects of a comprehensive swallowing rehabilitation program in patients with MSA to improve swallowing safety and efficiency. The study compares this approach to swallowing education alone, aiming to address dysphagia regardless of the MSA subtype. Participants receive either comprehensive swallowing rehabilitation, which includes functional muscle training, compensatory swallowing techniques, and thermal-tactile stimulation, or a single session of swallowing education. The rehabilitation involves twelve 30-minute sessions over six weeks, while the education group receives a single 30-minute session after the initial evaluation. During the study, participants undergo assessments including videofluoroscopic swallowing studies and various measures of respiratory and swallowing function at 6 and 12 weeks. Researchers monitor the Penetration-Aspiration Scale and Videofluoroscopic Dysphagia Scale as primary outcomes at 6 weeks, along with secondary outcomes such as cough strength, respiratory pressures, lung function, phonation time, and quality of life related to swallowing. The study continues with follow-up evaluations to assess changes over time and participant safety.
CONDITIONS
Brief Title
Comprehensive Swallowing Rehabilitation in Patients With MSA
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age over 19 years
- Clinically diagnosed with multiple system atrophy according to the 2nd consensus Gilman criteria
- Diagnosed with swallowing difficulties by a physiatrist
- Two or more points on the Penetration-Aspiration Scale from a videofluoroscopic swallowing study within the last 3 months
You will not qualify if you...
- Moderate to severe cognitive dysfunction with Mini-mental State Examination score below 19
- Comorbidities or structural abnormalities affecting swallowing function
- Other medical conditions that make participation difficult
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 6 weeks
Participants receive comprehensive swallowing rehabilitation or swallowing education to improve swallowing safety and efficiency.
12 sessions of rehabilitation over 6 weeks or 1 education session immediately after baseline evaluation
Duration - 6 weeks
Participants are monitored to assess swallowing function and respiratory measures after treatment completion.
Assessments at 6 weeks and 12 weeks after treatment start
Trial Site Locations
Total: 1 location
1
Seoul National University Hospital
Seoul, South Korea, 03080
Actively Recruiting
Research Team
H
Han Gil Seo, MD, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here